Skip to content

Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) Patients

Use Of Capnography As Surrogate Measure Of PC02 In Medical ICU Patients

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00744614
Enrollment
70
Registered
2008-09-01
Start date
2007-11-30
Completion date
2010-10-31
Last updated
2010-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease

Keywords

PC02, Respiratory Rate, Arterial blood gas, Intubation, Capnography

Brief summary

The purpose of this study is to evaluate the use of Capnography (Continuous recording of the carbon dioxide content of expired air)as an alternative test to measure PC02 levels in patients with asthma, chronic obstructive pulmonary (COPD,interstitial lung disease(ILD)or coronary disease who are at risk of intubation.

Detailed description

This is a prospective study to evaluate the usefulness of capnography as a non-invasive, accurate method of measuring of PC02 levels in medical intensive care unit patients with asthma, COPD, ILD, or coronary disease who are at risk of intubation.

Interventions

PROCEDURECapnography

A technique for monitoring the concentration or partial pressure of CO2 levels in respiratory gases

Sponsors

Lahey Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Medical Intensive Care Patients * Not intubated * Age 18 or older * History of any one of the following: asthma, COPD, ILD, or coronary disease

Exclusion criteria

* Sepsis * Life expectancy less than 1 month * Requiring BIPAP

Design outcomes

Primary

MeasureTime frame
PCO2 level6 months

Secondary

MeasureTime frame
Time to intubation6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026